Description
A kavalactone; a P-gp inhibitor that increases calcein AM uptake by 50% in P388 mouse leukemia cancer cells overexpressing P-gp at 54.6 μM; has analgesic activity, increasing the latency to tail withdrawal in the tail-flick assay in mice at 275 mg/kg; decreases the infarct size in a mouse model of MCA-induced ischemia at 10 mg/kg
Formal name: (6S)-6-[2-(1,3-benzodioxol-5-yl)ethyl]-5,6-dihydro-4-methoxy-2H-pyran-2-one
Synonyms: NSC 112159
Molecular weight: 276.3
CAS: 19902-91-1
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Natural Products||Product Type|Biochemicals|Transporter & Exchanger Modulators||Research Area|Cancer|Multidrug Resistance||Research Area|Neuroscience|Neuroprotection|Ischemia||Research Area|Neuroscience|Pain Research